Cytosorbents (CTSO) Capital Expenditures (2011 - 2026)
Cytosorbents (CTSO) reported Capital Expenditures of $11000.0 for Q1 2026, up 450.0% on a YoY basis from $2000.0 in Q1 2025, and down 89.81% quarter-over-quarter from $108000.0 in Q4 2025.
Cytosorbents (CTSO) Capital Expenditures (2011 - 2026) Analysis & Trends
Cytosorbents has reported Capital Expenditures for 16 years, with the latest figure at $11000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 450.0% year-over-year to $11000.0; the trailing twelve-month figure through Mar 2026 stood at $173000.0 (down 28.16% YoY), and the FY2025 full-year result was $164000.0, down 42.25% from the prior year.
- Capital Expenditures for Q1 2026 stood at $11000.0, down from $108000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $5.8 million in Q4 2022, with the low at -$5.0 million in Q3 2022.
- Historically, Capital Expenditures has averaged $442780.0 across 5 years, with a median of $82248.5 in 2023.
- Annual changes were most pronounced in 2022 — Capital Expenditures tumbled 306.94% — and 2026, when it soared 450.0%.
- Cytosorbents' Capital Expenditures stood at $5.8 million in 2022, then slumped by 98.36% to $95497.0 in 2023, then retreated by 27.75% to $69000.0 in 2024, then surged by 56.52% to $108000.0 in 2025, then slumped by 89.81% to $11000.0 in 2026.
- The last three Capital Expenditures figures came in at $11000.0 (Q1 2026), $108000.0 (Q4 2025), and $17000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn | 11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Jun 30, 2024 | 17,809.00 |
| Jun 30, 2024 | 17,809.00 |
| Mar 31, 2024 | 45,191.00 |
| Mar 31, 2024 | 45,191.00 |
| Dec 31, 2023 | 95,497.00 |
| Dec 31, 2023 | 95,497.00 |